| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cautionary note on the use of the missing indicator method for handling missing data in prediction research
|
van Smeden, Maarten
|
|
|
125 |
C |
p. 188-190
|
artikel
|
| 2 |
Agreement was moderate between data-based and opinion-based assessments of biases affecting randomized trials within meta-analyses
|
Turner, Rebecca M.
|
|
|
125 |
C |
p. 16-25
|
artikel
|
| 3 |
A large number of COVID-19 interventional clinical trials were registered soon after the pandemic onset: a descriptive analysis
|
Nasrallah, Ali A.
|
|
|
125 |
C |
p. 170-178
|
artikel
|
| 4 |
An overview of platform trials with a checklist for clinical readers
|
Park, Jay J.H.
|
|
|
125 |
C |
p. 1-8
|
artikel
|
| 5 |
An updated and more efficient search strategy to identify primary care–relevant clinical prediction rules
|
Ebell, Mark H.
|
|
|
125 |
C |
p. 26-29
|
artikel
|
| 6 |
Calibration slope versus discrimination slope: shoes on the wrong feet
|
Wang, Junfeng
|
|
|
125 |
C |
p. 161-162
|
artikel
|
| 7 |
Clinical trials are only as good as the patient- important outcome measures assessed
|
|
|
|
125 |
C |
p. A7-A9
|
artikel
|
| 8 |
Controversy and Debate Series on Core Outcome Sets. Paper 4: Debate on Paper 1 from the perspective of COMET [Core Outcome Measures in Effectiveness Trials]
|
Williamson, Paula R.
|
|
|
125 |
C |
p. 222-224
|
artikel
|
| 9 |
Controversy and Debate Series on Core Outcome Sets. Paper 2: Debate on Paper 1 from the perspective of OMERACT [Outcome Measures in Rheumatology]
|
Maxwell, Lara J.
|
|
|
125 |
C |
p. 213-215
|
artikel
|
| 10 |
Controversy and Debate Series on Core Outcome Sets. Paper 1: Improving the generalizability and credibility of core outcome sets (COS) by a large and international participation of diverse stakeholders
|
Chevance, Astrid
|
|
|
125 |
C |
p. 206-212.e1
|
artikel
|
| 11 |
Controversy and Debate Series on Core Outcome Sets. Paper 6: Improving the generalizability, credibility and implementation of core outcome sets – the example of the Cochrane Skin-Core Outcome Set Initiative (CS-COUSIN)
|
Schmitt, Jochen
|
|
|
125 |
C |
p. 229-231
|
artikel
|
| 12 |
Controversy and Debate Series on Core Outcome Sets. Paper 5: Large-scale, mixed-methods, knowledge exchange to establish core outcomes – the SONG approach
|
Carter, Simon A.
|
|
|
125 |
C |
p. 225-228
|
artikel
|
| 13 |
Controversy and Debate Series on Core Outcome Sets. Paper 7: Response to comments on the paper 2-6 re “Improving the generalizability and credibility of Core Outcome Sets (COSs) by involving large international sample of participants”
|
Chevance, Astrid
|
|
|
125 |
C |
p. 232-234
|
artikel
|
| 14 |
Controversy and Debate Series on Core Outcome Sets: The SOLAR (Standardized Outcomes Linking Across StakeholdeRs) system and hub and spokes model for direct core outcome measures in health care and its relation to GRADE
|
Schünemann, Holger J.
|
|
|
125 |
C |
p. 216-221
|
artikel
|
| 15 |
Counterfactual clinical prediction models could help to infer individualized treatment effects in randomized controlled trials—An illustration with the International Stroke Trial
|
Nguyen, Tri-Long
|
|
|
125 |
C |
p. 47-56
|
artikel
|
| 16 |
Current approaches to handling rescue medication in asthma and eczema randomized controlled trials are inadequate: a systematic review
|
Chis Ster, Anca Maria
|
|
|
125 |
C |
p. 148-157
|
artikel
|
| 17 |
Data From Web-Based Questionnaires Were Valid for Gestational Diabetes and Preeclampsia, but Not Gestational Hypertension
|
Beekers, Pim
|
|
|
125 |
C |
p. 84-90
|
artikel
|
| 18 |
Ecological momentary assessments (EMAs) did not improve responsiveness of patient-reported outcomes on quality of life
|
Boesen, Victor Brun
|
|
|
125 |
C |
p. 138-147
|
artikel
|
| 19 |
Editorial Board
|
|
|
|
125 |
C |
p. IFC
|
artikel
|
| 20 |
Equity was rarely considered in Cochrane Eyes and Vision systematic reviews and primary studies on cataract
|
Evans, Jennifer
|
|
|
125 |
C |
p. 57-63
|
artikel
|
| 21 |
Intrinsic motivation of GPs was not related to recruitment success, whereas interest in the study topic was
|
van der Worp, Henk
|
|
|
125 |
C |
p. 158-160
|
artikel
|
| 22 |
Methods used in the selection of instruments for outcomes included in core outcome sets have improved since the publication of the COSMIN/COMET guideline
|
Gorst, Sarah L.
|
|
|
125 |
C |
p. 64-75
|
artikel
|
| 23 |
Missing data should be handled differently for prediction than for description or causal explanation
|
Sperrin, Matthew
|
|
|
125 |
C |
p. 183-187
|
artikel
|
| 24 |
“One more time”: why replicating some syntheses of evidence relevant to COVID-19 makes sense
|
Page, Matthew J.
|
|
|
125 |
C |
p. 179-182
|
artikel
|
| 25 |
Pandemics and methodological developments in epidemiology history
|
Morabia, Alfredo
|
|
|
125 |
C |
p. 164-169
|
artikel
|
| 26 |
Placebo run-in periods in anticholinergic trials are not associated with treatment effect size or risk of attrition: an empirical evaluation
|
Karahalios, Amalia
|
|
|
125 |
C |
p. 120-129
|
artikel
|
| 27 |
Primary care functioning scale showed validity and reliability in patients with chronic conditions: a psychometric study
|
Postma, Simone A.E.
|
|
|
125 |
C |
p. 130-137
|
artikel
|
| 28 |
Quality and risk of bias appraisals of systematic reviews are inconsistent across reviewers and centers
|
Gates, Michelle
|
|
|
125 |
C |
p. 9-15
|
artikel
|
| 29 |
Reply to “Calibration slope versus discrimination slope: shoes on the wrong feet”: validation stands on three feet, not two
|
Stevens, Richard J.
|
|
|
125 |
C |
p. 162-163
|
artikel
|
| 30 |
Response changes in Delphi processes: why is it important to provide high-quality feedback to Delphi participants?
|
Khodyakov, Dmitry
|
|
|
125 |
C |
p. 160-161
|
artikel
|
| 31 |
Rethinking the intention-to-treat principle: one size does not fit all
|
Oude Rengerink, Katrien
|
|
|
125 |
C |
p. 198-200
|
artikel
|
| 32 |
Risk scores did not reliably predict individual risk of mortality for patients with decompensated heart failure
|
Scrutinio, Domenico
|
|
|
125 |
C |
p. 38-46
|
artikel
|
| 33 |
Table of Contents
|
|
|
|
125 |
C |
p. A3-A6
|
artikel
|
| 34 |
The adapted Zelen was a feasible design to trial exercise in myeloma survivors
|
Land, Joanne
|
|
|
125 |
C |
p. 76-83
|
artikel
|
| 35 |
The importance of decision intent within descriptions of pragmatic trials
|
Nicholls, Stuart G.
|
|
|
125 |
C |
p. 30-37
|
artikel
|
| 36 |
The number needed to treat for net effect (NNTnet) as a metric for measuring combined benefits and harms
|
Li, Guowei
|
|
|
125 |
C |
p. 100-107
|
artikel
|
| 37 |
The Swedish Hip Fracture Register and National Patient Register were valuable for research on hip fractures: comparison of two registers
|
Meyer, Anna C.
|
|
|
125 |
C |
p. 91-99
|
artikel
|
| 38 |
Updating systematic reviews can improve the precision of outcomes: a comparative study
|
Gao, Ya
|
|
|
125 |
C |
p. 108-119
|
artikel
|
| 39 |
We need to talk about peer-review—Experienced reviewers are not endangered species, but they need motivation
|
Ellwanger, Joel Henrique
|
|
|
125 |
C |
p. 201-205
|
artikel
|
| 40 |
What to do with all the AGREEs? The AGREE portfolio of tools to support the guideline enterprise
|
Brouwers, Melissa C.
|
|
|
125 |
C |
p. 191-197
|
artikel
|
Tijdschrift beschrijving